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Learning Objectives 
1. To identify the spectrum of 
peripartum mood disorders, their 
features, diagnostic criteria, and 
treatments. 
2. To review FDA pregnancy safety 
categories and lactation 
categories for commonly 
prescribed mood medications. 
3. To identify the role of family 
physicians in identifying and 
treating peripartum mood 
disorders. 
Definitions 
“Baby blues” = feelings of depression or anxiety that start soon after delivery and 
generally self-resolve without intervention within 2 weeks. 
6
Postpartum depression (PPD) = minor depressive symptoms or unipolar major 
depressive disorder occurring during pregnancy or in the 4 weeks (academic 
definition) - 12 months (used in clinical practice) after delivery. 
2
Postpartum anxiety (PPA) = anxiety disorders, including OCD, present in the 
perinatal period. 
2
Postpartum psychosis (PPP) = disorganization, hallucinations, and/or bizarre behavior 
that occurs within 4 weeks of delivery. 
14
Relevance to primary care 
and the role of family 
medicine: 
Role of Family Medicine  
Approximately ⅓ of pregnant women in the U.S. have received some form of care 
(prenatal or otherwise) from a family medicine physician in the past year. 
5
Family medicine providers see patients in the preconception phase when they can 
identify potential risk factors for perinatal mood disorders and optimize management.
Family medicine providers see infants for more frequent visits after birth, presenting 
opportunities to also check in with new parents.  
Epidemiology and Natural Course of the “Baby Blues” 
In a systematic review and meta analysis of publications from three international 
databases, authors found that the prevalence of “baby blues” was around 39%. 
8
The term, “baby blues,” is frequently used to describe a constellation of symptoms 
including anxiety, sadness, irritability, sleep disturbances, appetite changes, confusion 
and fatigue that most commonly begins 2-5 days after delivery and persists for no more 
than 2 weeks. 
9
Important to note, “baby blues,” does not impair daily functioning or ability to care for 
the baby and resolves without treatment. 
9
Case #1: Beatrice  
Case #1 
Beatrice is a 24y/o G4P4 with PMH MDD (on no meds in pregnancy), gHTN who sees 
you in the office 3 weeks postpartum for an infant weight check. She is accompanied 
by her 3 other children, all of whom are screaming when you enter the exam room. She 
expresses concern that she will not be able to figure out how to get her newborn 
insurance by the time he is 1 month old. She currently has Keystone First. 
What risk factors does this patient have for developing postpartum depression? 
Epidemiology of Postpartum Depression  
World-wide rates of PPD vary significantly.
1
 
● High-income countries (including the U.S.): 7-13%
● Low/Middle-income countries: 20% 
Risk factors for developing PPD include: 
2
● History of prior mood disorder 
● Family history of PPD 
● Poor support systems 
Reference 2 
Case #1 
Beatrice is a 24y/o G4P4 with PMH MDD (on no meds in pregnancy), gHTN who sees 
you in the office 3 weeks postpartum for an infant weight check. She is accompanied 
by her 3 other children, all of whom are screaming when you enter the exam room. She 
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Epidemiology of Postpartum Depression  
One U.S. study estimated that 27% of PPD begins pre-pregnancy and 33% of PPD 
begins during pregnancy. 
3
Poor identification and measurement of symptoms in pregnancy may lead to women 
being classified as having postpartum onset of symptoms as opposed to peripartum 
onset of symptoms. 
Some evidence suggests that depressive symptoms may actually be more prevalent 
during pregnancy than after delivery. 
4
Pathophysiology: Possible Role of Reproductive Hormones in PPD 
Although most risk factors for PPD are not necessarily specific to the perinatal period, 
there is some evidence that suggests the existence of a subtype of PDD characterized 
by sensitivity to fluctuating reproductive hormone levels. 
2
Rapid changes in estradiol and progesterone following delivery can trigger the onset of 
symptoms in susceptible women with this phenotype. 
9
Low levels of oxytocin in the third trimester are correlated with increased depressive sx 
during pregnancy and after delivery. 
9
Screening and Diagnosis of Postpartum Depression 
DSM5 Criteria for diagnosis = a major 
depressive episode with peripartum onset. 
9
 
Five depressive symptoms (below) must be 
present for at least 2 weeks: 
● Depressed mood present most of day 
● Loss of interest or pleasure 
● Insomnia or hypersomnia 
● Psychomotor retardation or agitation 
● Worthlessness or guilt
● Lack of energy/fatigue 
● Impaired concentration/ indecisiveness
● Weight or appetite change
● Suicidal ideation 
Treatment of Postpartum Depression  
Mild-Moderate Postpartum Depression 
● Psychotherapy is first line. 9 
Moderate-Severe Postpartum Depression
● Combination of psychotherapy and pharmacotherapy is first line. 9  
● SSRIs,  SNRIs, Mirtazapine (minimum 6-12 months) 
● ECT for those who fail 4 consecutive medication trials, particularly helpful in 
settings of psychosis, plans for suicide/infanticide, refusal to eat. 
● IV Brexanalone for those who fail ECT, decline. 
Medication Risks in the Peripartum Period 
FDA Pregnancy Categories:
A - adequate studies have not shown risk to fetus 
in the first trimester (or beyond). 
B - animal studies have shown no risk to fetus. No 
data from human studies. 
C - adverse effects in animal studies. No data from 
human studies. Benefits > risks. 
D - evidence of fetal risk based on investigational 
or marketing studies in humans. Benefits may 
warrant use in certain situations. 
X -  evidence of fetal risk based on investigational 
or marketing studies in humans. Risks > Benefits 
Lactation Risk Categories:
L1 - no demonstrated risk to infant in controlled 
studies. 
L2 - studied in limited number of women without 
adverse effects in infants. 
L3 - No controlled studies in breastfeeding women. 
Risk is possible.  
L4 - Evidence of risk in breastfed infants. Benefits 
may warrant use in certain situations. 
L5 - Significant documented risk to infants. Risks > 
Benefits 








Sertraline (Zoloft) C L2 Considered a preferred antidepressant with 
breastfeeding 
Fluoxetine (Prozac) C L2/ L3 L2 (older infants) 
L3 (neonates) 
Paroxetine (Paxil) D L2 Significant withdrawal syndrome for infants 
exposed in utero. 
Citalopram (Celexa) C L3 Citalopram is less compatible with 
breastfeeding than escitalopram. 
Escitalopram (Lexapro) C L3 
Venlafaxine (Effexor) C L3







Bupropion (Wellbutrin) B L3
Mirtazapine (Remeron) C L3
Trazodone (Desyrel) C L2
Amitriptyline C L2 
Nortriptyline (Pamelor) C L2 
Duloxetine (Cymbalta) C -
Buspirone (Buspar) B L3 
Case #2: Ella  
Case #2
Ella is a 29y/o G1P1 who presents 6 weeks postpartum for her Liletta IUD insertion. 
Her Edinburgh score is a 9. As you reach for the door knob, she mentions that she has 
been feeling increasingly panicky over recent weeks. She perseverates frequently over 
fears that she will drop her new baby. These used to occur only when she was at a 
significant height or near a ledge, but now these intrusive thoughts occur almost any 
time she stands up holding the baby. Every time this happens, she reswaddles the baby 
and readjusts her grip. 
Which peripartum mood disorder might you be concerned about? 
Epidemiology of Postpartum Anxiety Disorders 
The prevalence of PPA has been estimated at approximately 13%, which approximates 
the prevalence of anxiety disorders in the population at large. 
2
There appears to be a significantly higher rate of obsessive compulsive disorder in 
pregnant and postpartum women than in non-pregnant women. 
2
Risk Factors include: 
12 
● Postpartum depression (often co-morbid) 
● Past history of mood disorders 
● Lack of social support 
● Low income/educational attainment 
Screening and Diagnosis of Postpartum Anxiety 
An EPDS may flag as positive due to the coexistence of multiple perinatal mood disorders. 
2
GAD-7 has not been validated for perinatal populations. 
11
 
Other screening tools exist but do not seem to be used in the clinical setting in which we 
work: 
11
● Postpartum Specific Anxiety Scale (PSAS) 10
○ 51 questions! 
● Brief Measure of Worry Severity (BMWS) 
○ Examines clinical and personality correlates of severe worriers 
● Cambridge Worry Scale (CWS) 
○ 16 questions related to pregnancy/birth specific situations 
● Pregnancy Related Anxiety Questionnaire Revised (PRAQ-R) 
○ Validated only in nulliparous (not parous) women 
Treatment of Postpartum Anxiety 
There is a significantly smaller body of research for perinatal mood disorders other 
than postpartum depression. 
Thus, most of the treatment methods for postpartum anxiety are extrapolated from the 
treatment of anxiety during other periods of life. 
Psychotherapy and medications such as SSRIs are mainstays of therapy. 
2
Benzodiazepines are considered FDA Class D during pregnancy due to small 
teratogenic risks in the first trimester and “floppy infant syndrome” if used close to 
delivery. They are considered L3 risk for breastfeeding. 
● ACOG: If benefits > risks, use them! 13  
Case #3: Maya 
Case #3 
Maya is a 44y/o G3P3003 with PMH bipolar I (stopped her meds halfway through 
pregnancy), cHTN, hypothyroidism on Synthroid who sees you in clinic PPD#6 for her 
infant’s weight check. She presents with her partner, who pulls you aside to confide in 
you that she is worried about Maya’s behavior. She reports that Maya has been having 
significant difficulty sleeping since bringing the infant home and yesterday became 
suddenly paranoid that her partner intended to harm the baby. She has been 
referencing events that her partner has no recollection of occuring. 
Which peripartum mood disorder might you be concerned about? 
Epidemiology of Postpartum Psychosis 
The prevalence of postpartum psychosis worldwide is approximately 0.2%. 
7





● Advanced maternal age 
● History of Bipolar I disorder 
● History of Postpartum Psychosis 
Screening and Diagnosis of Postpartum Psychosis 
The Mood Disorder Questionnaire (MDQ) is a 5-item screening questionnaire for bipolar 
disorder, validated for use both during and outside of the peripartum period. 
Typical onset of PPP is 3-10 days after delivery, and by DSM5 criteria, must occur within 4 
weeks of delivery. 
14 





● Bizarre behavior 
● Hallucinations (tactile, visual, olfactory > auditory) 
● Paranoid, grandiose delusions 
Treatment of Postpartum Psychosis 
Postpartum psychosis is a psychiatric emergency, and therefore an indication for 
hospitalization. 
Women with a history of postpartum psychosis should begin lithium therapy 
immediately after delivery as prophylaxis. 
14
Benzodiazepines are used for symptoms of insomnia and agitation in the treatment of 
PPP. 
15 
Atypical antipsychotics (Latuda, Abilify) and mood stabilizers can be used for 
psychotic and manic symptoms in the treatment of PPP. 
14 
Maintenance treatment with lithium monotherapy is recommended for at least 9 
months postpartum to decrease risk of relapse. 
15
Resources in Philadelphia: 
Resources in Philadelphia 
Maternity Care Coalition MoMobile 
Family Therapy Program:
● behavioral health services for 
low-income pregnant women and 
mothers with young children (ages 0 
to 3).  
● identifies and treats issues of perinatal 
depression and/or other behavioral 
health conditions such as PTSD, 
anxiety disorders, and co-occurring 
substance dependence. 
Take Home Points
1. There is a wide spectrum of 
peripartum mood disorders, not just 
postpartum depression! 
2. Mainstays of therapy for both 
postpartum anxiety and depression 
include psychotherapy and SSRIs. 
3. Postpartum psychosis is a psychiatric 
emergency warranting inpatient, 
multidisciplinary treatment. 
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